£59.98

Advance in the Treatment of Pediatric Leukemia

Pharmacology

Price data last checked 40 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£60 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days • 51 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 51 days • 1 price levels

Days at Price

Price Analysis

Most common price: £60 (51 days, 100.0%)

Price range: £60 - £60

Price levels: 1 different prices over 51 days

Description

The book gives an overview on the progress that has been made in the treatment of acute lymphoblastic leukemia (ALL), of acute and chronic myeloid leukemia (AML, CML) and of juvenile myelomonocytic leukemia (JMML). Leukemia is the most common malignant disease in children, and 80% of patients are diagnosed with ALL and 15-20% with AML, whereas CML and JMML are rather rare. Although ALL was considered an incurable disease until the early 1960s, with the availability of cytotoxic drugs and the start of clinical multicenter studies, ALL has become an almost curable disease with a survival rate exceeding 90 % in high-income countries. These impressive results have mainly been achieved by a deeper understanding of the genomic landscape of the disease and the introduction of risk stratifications based on genetic features and response to chemotherapy as determined by the presence or absence of minimal residual disease (MRD). Immunotherapies including bispecific T-cell Engagers (BiTEs), Chimeric Antigen Receptor (CAR) T cells, monoclonal antibodies and improvements in the outcome of allogeneic stem cell transplantation (HSCT) have shown impressive results in chemorefractory or relapsed patients, and it is anticipated that the cure rate can be further increased. For countries with less resources, therapies have to be adapted to increase survival as well. This book also updates on the progress made in the treatment of AML. As in ALL, risk classification based on genetic factors and response to chemotherapy is most important for therapy guidance. The book also provides updates and guidance for the treatment of CML and JMML.

Product Specifications

Format: hardcover
ASIN: 3036541675
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 01 June 2022
Listed Since: 08 June 2022

Barcode

No barcode data available

Advance in the Treatment of Pediatric Leukemia

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Chemotherapy for Leukemia: Novel Drugs and Treatment

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Leukemias

Prognostic Factors and Treatment Strategies (v. 8) (Haematology and Blood Transfusion)

Acute Myeloid Leukemia (Hematologic Malignancies)

Acute Leukemias (Hematologic Malignancies)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Biology and Treatment of Leukemia and Bone Marrow Neoplasms: 181 (Cancer Treatment and Research, 181)

Lanzkowsky's Manual of Pediatric Hematology and Oncology

Consulting Hematology and Oncology Handbook

Manual of Hematopoietic Cell Transplantation and Cellular Therapies

Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)

Academic Press - Treatment of Leukemia and Lymphoma Vol 51

Lanzkowsky's Manual of Pediatric Hematology and Oncology

Springer - New Agents for the Treatment of Acute Lymphoblastic Leukemia

Textbook of Uncommon Cancer

Springer - The Myelodysplastic Syndromes Medical Text

Springer - Advances in Chronic Lymphocytic Leukemia, Vol 792

Über die Lebensqualität von Patienten mit akuter myeloischer Leukämie: Eine differenzierende Beobachtungsstudie